Salix Pharmaceuticals (NASDAQ:SLXP) is a step closer to bringing to the U.S. Food and Drug Administration a once-a-day pill version of injectable constipation drug Relistor. Relistor is indicated for ...

The U.S. Food and Drug Administration will review a constipation drug marketed by Salix Pharmaceuticals (NASDAQ:SLXP) to consider adding a new indication for the product. Relistor is an injectable ...

Progenics Pharmaceuticals announced that it will hand over commercial duties on Relistor, a subcutaneous injection for opioid-induced constipation, to Salix Pharmaceuticals, beginning in April.

Progenics Pharmaceuticals announced that it will hand over commercial duties on Relistor, a subcutaneous injection for opioid-induced constipation (OIC), to Salix, beginning in April. Financial terms ...

Salix Pharmaceuticals ($SLXP) nabbed the new Relistor approval it was counting on. The FDA blessed the injectable drug as a treatment for all patients with ...

The companies are looking to get Relistor approved for the treatment of opioid-induced constipation (:OIC) in patients taking opioids for chronic non-cancer pain. Relistor is a peripherally acting ...

With oral Relistor's approval, Valeant just got a new weapon in its battle with AstraZeneca for the opioid-induced constipation throne. Can that weapon reach the billion-dollar sales benchmark quoted ...

Relistor approved for OIC Salix and Progenics announced that the Food and Drug Administration (FDA) has approved Relistor (methylnaltrexone) subcutaneous injection for the treatment of opioid-induced ...

Please provide your email address to receive an email when new articles are posted on . The FDA has accepted for review the new drug application submitted for oral Relistor tablets for the treatment ...

Please provide your email address to receive an email when new articles are posted on . A single dose of Relistor injection produced rescue-free laxation in severely ill patients with opioid-induced ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Health Canada and ...

Relistor approved for OIC Pfizer and Progenics are notifying healthcare professionals and patients that the kit presentation of Relistor (methylnaltrexone bromide) subcutaneous injection contains ...